BioLargo (BLGO) Aandeel Koers

BioLargo Koers

OTC·GESLOTEN
0,08
​
Markt gesloten

In de afgelopen 18 jaar liet BioLargo de omzet jaarlijks met 28,9% groeien tot 7,77 Miljoen USD. Bij BioLargo is de nettowinstmarge met -151,7% ten opzichte van -279,7% enkele jaren geleden gestegen. Het consensus-koersdoel voor BioLargo op 12 maanden bedraagt 0,31 USD, circa 282,5% boven de huidige koers. Van de 8 analisten geven 7 het aandeel een koopadvies — per saldo een Kopen-consensus.

BioLargo aandeelkoers

Deze data ophalen via de Eulerpool API

100.000 requests/maand gratis · geen creditcard

BioLargo bedrijfsmodel & aandelenanalyse

BioLargo Inc is een Amerikaans bedrijf dat oorspronkelijk in 1991 werd opgericht en zijn hoofdkantoor heeft in Westminster, Californië. Het bedrijf is actief in diverse sectoren, waaronder milieu, gezondheid en industrie. BioLargo ontwikkelt en brengt innovatieve technologieën en producten op de markt voor gebruik in verschillende toepassingsgebieden. Het bedrijf beschikt over meerdere patenten wereldwijd en staat bekend om zijn baanbrekende uitvindingen en expertise.

Veelgestelde vragen over BioLargo

BioLargo Inc is a diversified environmental company focused on developing innovative technologies to address various global challenges. The business model of BioLargo Inc revolves around commercializing and licensing its proprietary technologies in areas such as water and air treatment, advanced wound care, and animal health. The company combines research, development, and commercialization to bring sustainable solutions to market. BioLargo Inc aims to create value for its shareholders by developing and marketing cost-effective and efficient products that provide significant benefits to industries and communities alike.

BioLargo Inc is primarily active in the fields of water treatment, environmental sustainability, and industrial solutions.

The main competitors of BioLargo Inc in the market are [competitor 1], [competitor 2], and [competitor 3]. These companies have established a strong presence in the [relevant industry] sector, competing with BioLargo Inc on various fronts. However, BioLargo Inc has continuously demonstrated its unique competitive advantage through its innovative [products/services] and commitment to [industry-specific goals]. With its extensive expertise and strategic initiatives, BioLargo Inc remains a formidable player in the market, consistently striving for growth and market leadership.

BioLargo Inc is a globally recognized company specializing in innovative water and environmental technologies. Established in 1989, BioLargo has dedicated years of research and development to create cutting-edge products aimed at solving some of the world's biggest challenges, including clean water availability and air quality. The company is renowned for its proprietary technology called Advanced Oxidation System (AOS), which effectively eliminates contaminants in water with high efficiency. With a strong commitment to sustainability and environmental responsibility, BioLargo continues to revolutionize industries such as water treatment, oil and gas, food processing, and more. The company's relentless pursuit of excellence positions BioLargo as a leader in providing transformative solutions for a healthier planet.

BioLargo Inc has achieved significant milestones throughout its history. It has developed innovative and sustainable technologies for various industries. Some notable achievements include the commercialization of its highly effective odor control products, such as CupriDyne Clean, which addresses odor issues across multiple sectors. The company has also successfully developed and patented its AOS water treatment system, which offers cost-effective and efficient solutions for contaminated water treatment. Furthermore, BioLargo has formed strategic partnerships and collaborations with leading organizations, enhancing its market reach and potential. These milestones demonstrate BioLargo Inc's commitment to finding innovative solutions for environmental challenges and establishing itself as a leader in its industry.

BioLargo Inc primarily operates in the United States. As a leading environmental engineering company, BioLargo provides innovative solutions for air and water pollution control, odor and moisture management, and sustainable energy technologies. The company's headquarters is located in California, with operations and partnerships across different states in the U.S. BioLargo Inc is focused on delivering cost-effective, scalable, and eco-friendly solutions to address major environmental challenges.

BioLargo Inc represents a commitment to innovation, sustainability, and environmental responsibility. The company's corporate philosophy is centered around providing cutting-edge solutions for water and air quality challenges. BioLargo believes in developing and commercializing advanced technologies that address crucial global issues, such as pollution, water scarcity, and climate change. With a focus on research and development, BioLargo strives to create sustainable and cost-effective products that improve the quality of life for people and the planet. As a leader in environmental solutions, BioLargo Inc continues to demonstrate its dedication to making a positive impact on the world through its values and corporate philosophy.

Analisten hanteren momenteel een gemiddeld koersdoel van 0,31 USD voor het aandeel BioLargo (mediaan: 0,31 USD), oftewel +282,5 % ten opzichte van de laatste koers. De consensus is gebaseerd op 8 analistenratings.

7 analisten beoordelen het aandeel BioLargo momenteel: 6 adviseren kopen, 1 houden en 0 verkopen. Voor 2026 verwachten analisten dat BioLargo een omzet van 5,23 Miljoen USD en winst per aandeel van -0,05 USD behaalt.

Omgezet tegen de huidige wisselkoers noteert het aandeel BioLargo op 0,07 EUR (0,08 USD).

BioLargo Inc is an innovative company specializing in the development and marketing of environmentally friendly technologies. The company's business model is designed to create a sustainable future by providing solutions to some of the world's most urgent environmental problems. The company operates in three business segments: BioLargo Water, BioLargo Engineering, and BioLargo Sciences. Each division offers specialized technologies and products tailored to customer needs. BioLargo Water specializes in water treatment and desalination. The company has developed an award-winning technology called AOS, which is one of the most effective in the market. AOS stands for Advanced Oxidation System and uses a unique combination of ozone and ultraviolet light to achieve high water quality. The company also offers products such as water filters and desalination systems. BioLargo Engineering focuses on solving environmental engineering problems. It provides specialized engineering services and technical consulting to customers experiencing issues in their facilities. The company has developed a unique method to disinfect air streams without the release of harmful chemicals. The technology is called CupriDyne Clean and aims to control odors and VOCs in the air. BioLargo Sciences specializes in the development of technologies for the medical and healthcare industries. The company specializes in combating infectious diseases and biological threats. It has developed a patented technology called Clyraguard, which provides long-lasting disinfection. The company also offers products such as hand sanitizers and mouth rinses. BioLargo Inc is an environmentally-focused company that has developed multiple patented technologies in the fields of environmental engineering, health, and medicine. The company strives to offer customers effective and environmentally friendly solutions, making the planet a better place. The company has a track record of success stories, such as successfully implementing the AOS technology in a Canadian gold mine to clean wastewater. It has also improved the process of air disinfection in poultry farms, leading to improved quality of life for the animals. BioLargo Inc has an experienced leadership team composed of experts from various fields, including engineers, scientists, entrepreneurs, and environmentalists. The management team has a strong vision for the future and is working hard to achieve their goals. Overall, BioLargo Inc offers a wide range of environmentally friendly technologies and products. The company aims to provide customers with effective and safe solutions to solve some of the world's most urgent environmental problems.

De verwachte omzet van BioLargo bedraagt 5,23 Miljoen USD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.

De verwachte winst van BioLargo bedraagt -15,35 Miljoen USD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.

De koers-winstverhouding (P/E) van BioLargo bedraagt momenteel -1,65. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het BioLargo-aandeel in te schatten.

De koers-omzetverhouding (P/S) van BioLargo bedraagt momenteel 4,86. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het BioLargo-aandeel.

De Eulerpool Kwaliteitsscore voor BioLargo is 4/10.

De ISIN van BioLargo is US09065A1007. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.

De WKN van BioLargo is A0MLEC. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.

Het tickersymbool van BioLargo is BLGO. Onder dit beurstickersymbool wordt het BioLargo-aandeel op de beurs verhandeld.

Fair ValueTerminal
0,07 USD
Over-/OnderwaarderingTerminal
Redelijk gewaardeerd
Industrie
Chemicaliën
Aantal aandelen
Werknemers
Omzet per werknemer
176.477,27 USD
Omzetgroei Ø5 jaar
EBIT-groei Ø5 jaar
Nettowinst-groei Ø5 jaar
Website biolargo.com
Valuta
USD
Beursintroductie
12 dec 1991
ISIN
US09065A1007
CUSIP
09065A100
SEDOL
B1VNGK6
Marktkapitalisatie
52-weekbereik
AAQS
4 / 10
PEG-ratio
—
K/W-ratio
K/We 2026
-1,65
K/We 2027
-2,76
K/O-ratio
K/Oe
4,86
EV/EBIT
—
Koers-Boekverhoudung
16,09
ROE (Rendement op Eigen Vermogen)
ROA (Rendement op Activa)
ROCE (Rendement op Ingebruikt Kapitaal)
ROIC (Rendement op Geïnvesteerd Kapitaal)
-553,83 %
Laatst bijgewerkt 17 okt 2026, 01:23

BioLargo Ticker

OTC · BLGOOTC · BLGO

BioLargo FIGI

BLGO:US · BBG000FQ9DS7BLGO:PQ · BBG000FQ9RB4BLGO:UV · BBG000FQ9SV0BLGOEUR:EO · BBG00DLFBJP3BLGOEUR:XH · BBG00DLFBJS0BLGOEUR:XF · BBG00DLFBJV6BLGOEUR:XE · BBG00DLFBJX4BLGOEUR:XJ · BBG00DLFBJY3BLGOEUR:XL · BBG00DLFBJZ2BLGOEUR:XG · BBG00DLFBK07BLGOEUR:XO · BBG00DLFBK16BLGOEUR:XS · BBG00DLFBK52

Alle fundamentals en diepgaande analyse van BioLargo

Onze aandelenanalyse van het BioLargo-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van BioLargo. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: